Telehealth Solutions and NHS Islington Use Pharmacies to Save Lives

Telehealth SolutionsIslington residents can now receive a 30 minute consultation that calculates their risk of having a heart attack, stroke or developing diabetes in the next ten years - at their local pharmacy.

NHS Islington is using Telehealth Solutions' CardioPods in 10 pharmacies in the area to measure blood pressure, BMI, cholesterol and blood sugar. The readings are then used to assess a patient's risk of developing cardiovascular disease and sent directly to their GP.

Islington has areas with some of the highest levels of economic deprivation in the country, and has high rates of deaths from cardiovascular disease, especially among under-75s. The idea is to identify risk factors for cardiovascular disease and diabetes, and supporting people to reduce or manage their individual risks.

This can include support to stop smoking, lifestyle advice such as sensible drinking, simple ways to increase physical activity, and how to maintain a healthy diet. Where medical advice is required, pharmacists will advise the patients and refer them to their GP.

Paul Whitehouse, Telehealth Solutions' Business Strategist for Public Health said: "Cardiovascular disease costs the UK more than £17 billion in healthcare resource. If we can catch people earlier, before they have an incident, then we can not only save the NHS massive costs over the next ten years - we can save people's lives."

Related news articles:

About Telehealth Solutions
Telehealth Solutions was founded in 2006 to bring the convergence of technology and changing clinical practice to the benefit of patients and clinicians. The company has since grown rapidly both in the UK and internationally. Its employees are dedicated to providing the most secure, scalable and robust methods for collecting information from patients, without the need for clinical intervention, and getting that information to clinicians and carers looking after those patients.

www.thsl.co.uk

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

DigiConnect: e-healthcare - 24/7 Health …

Given the current outbreak of COVID-19, healthcare providers in the Middle East along with the rest of the world are currently putting relentless efforts to provide an innovative offering that...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...